Eradication of Neuroblastoma by T Cells Redirected with an Optimized GD2-Specific Chimeric Antigen Receptor and Interleukin-15.
Yuhui ChenChuang SunElisa LandoniLeonid MetelitsaGianpietro DottiBarbara SavoldoPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2019)
Our results guide new therapeutic options for GD2.CAR-Ts in patients with neuroblastoma, and CAR-T development for a broad range of solid tumors.
Keyphrases